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Group B streptococcal (GBS) infection is a major cause of neonatal mortality and morbidity. Host factors responsible for immunity to GBS include specific antibody, functional neutrophils and intact complement pathways. The role of cell-mediated immunity is unknown. To investigate the relationship between humoral immunity and cell-mediated immunity to GBS, the in vitro lymphocyte response to whole bacteria was studied in 13 healthy adult volunteers. Lymphocytes were isolated and cultured in 15% autologous serum in microtiter plates. Each well contained 2 X 106 cells and either 1) washed formalin killed type 111 GBS in cell to organism ratios of 1:10, 1:1, or 1:0.1, 2) PHA, or 3) SK:SD. 3~ thymidine incorporation was measured at 5,6 or 7 days. The serum concentration of type 111 GBS antibody was determined with an enzyme immunoassay. Six of 13 adults responded to type 111 GBS as defined by a stimulation index of >10 or absolute count >4000 CPM. The mean serum concentration of type 111 GBS antibody in responders (15.5k7.4 M+ SEM ug/ml) did not differ significantly from non-responders (6.050.1 ug/ml) . Maximal response to GBS occurred at a cell/organism ratio of 1:1, (p<.05). Thymidine incorporation was significantly greater at 6 days than at 5 or 7 days (p<.005). The in vitro lymphocyte response to type 111 GBS may be an important determinant of host susceptibility to infection. It is unknown why only 1 in 100 colonized infants develop GBS disease. There have been several semiquantitative studies of colonization in mothers, but no quantitative studies on magnitude of colonization in infants. This study was designed to determine if infants symptomatic for early-onset GBS disease (respiratory distress) are heavily colonized with the bacteria. Newborn infants suspected of early-onset disease at Tampa General Hospital were cultured at three or more sites with culturetteR dual swabs. The swabs were used for identification of GBS by slide co-agglutination and enumeration of the bacteria by viable plate count. Eleven (13%) of 85 infants cultured were found to be colonized with GBS at one or more sites. Two of these eleven colonized infants were symptomatic for early-onset GBS disease. Both symptomatic infants were heavily colonized (22.9 x 103 bacteria/swab) with GBS of serotype I. In comparison, only one of the nine asymptomatic infants was colonized with GBS of serotype I and the colonization was of a low magnitude (<2.0 x 10' bacteria/swab).
ENUMERATION OF GROUP B STREPTOCOCCI (GBS
The other eight infants were colonized with nontype I GBS, generally at low numbers. The two asymptomatic infants that were heavily colonized with GBS were colonized with bacteria of serotype 111. These preliminary data suggest a possible correlation between heavy colonization of neonates with specific serotypes of GBS and the development of early-onset group B disease. A series of longitudinal studies of otitis media secondary to three strains of bacterial pathogens were conducted in the chinchilla animal model in order to define the importance of local and systemic mechanisms for the protection of the middle ear.
The three strains of bacteria used were: Streptococcus pneumoniae type 6A and type 7F, and 8-lactamase producing non-typable -Haemophilus influenzae. Initially, the bacteria were inoculated unilaterally into the epitympanic bulla. Following the resolution of the induced otitis media with effusion, bacterial challenges were repeated ipsilaterally and contralaterally. Middle ear condition was assessed employing otomicroscopy , tympanometry and periodic direct inspection and culture. The results for the three strains of bacteria were similar. The ipsilateral middle ear was resistant to subsequent infection whereas the contralateral middle ear evidenced a disease course similar to that induced by the initial challenge. Thus resistance to subsequent infection appears to be a local phenomenon with little systemic participation.
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